Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    16678561 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients
Condition: Depressive Disorder
Intervention: Drug: Paroxetine CR
2 Recruiting Fructose and Fructans in IBS
Condition: Irritable Bowel Syndrome
Interventions: Dietary Supplement: Glucose;   Dietary Supplement: Fructose;   Dietary Supplement: Fructans
3 Recruiting Effect of Lactobacillus Casei DG (Enterolactis Plus®) in Patient With Irritable Bowel Syndrome: a Pilot Study
Condition: Irritable Bowel Syndrome
Interventions: Dietary Supplement: Lactobacillus casei DG;   Dietary Supplement: Placebo

Indicates status has not been verified in more than two years